{"id":"https://openalex.org/W7160761852","doi":"https://doi.org/10.3389/fbioe.2026.1798323","title":"A 3D bioengineered human liver for the study of acute and chronic drug-induced hepatotoxicity and fibrosis","display_name":"A 3D bioengineered human liver for the study of acute and chronic drug-induced hepatotoxicity and fibrosis","alternate_titles":[],"publication_year":2026,"publication_date":"2026-05-10","ids":{"openalex":"https://openalex.org/W7160761852","doi":"https://doi.org/10.3389/fbioe.2026.1798323","pmid":"https://pubmed.ncbi.nlm.nih.gov/42186602","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13198925"},"language":"en","primary_location":{"id":"doi:10.3389/fbioe.2026.1798323","doi":"https://doi.org/10.3389/fbioe.2026.1798323","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fbioe.2026.1798323","pdf_url":"https://www.frontiersin.org/journals/bioengineering-and-biotechnology/articles/10.3389/fbioe.2026.1798323/pdf","source":{"id":"https://openalex.org/S2595131146","display_name":"Frontiers in Bioengineering and Biotechnology","issn_l":"2296-4185","issn":["2296-4185"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Bioengineering and Biotechnology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W7160761852"],"child_works_count":1,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/bioengineering-and-biotechnology/articles/10.3389/fbioe.2026.1798323/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5015845279","display_name":"Ainhoa Ferret-Mi\u00f1ana","orcid":"https://orcid.org/0000-0002-2254-2746","observed_orcids":["https://orcid.org/0000-0002-2254-2746"]},"institutions":[{"id":"https://openalex.org/I4210147769","display_name":"Institute for Bioengineering of Catalonia","ror":"https://ror.org/056h71x09","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210132884","https://openalex.org/I4210147769","https://openalex.org/I4387153040"]},{"id":"https://openalex.org/I71999127","display_name":"Universitat de Barcelona","ror":"https://ror.org/021018s57","country_code":"ES","type":"education","lineage":["https://openalex.org/I71999127"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Ainhoa Ferret-Mi\u00f1ana","raw_affiliation_strings":["Biosensors for Bioengineering Group, Institute for Bioengineering of Catalonia (IBEC), Barcelona, Spain","Universitat de Barcelona (UB), Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biosensors for Bioengineering Group, Institute for Bioengineering of Catalonia (IBEC), Barcelona, Spain","institution_ids":["https://openalex.org/I4210147769"]},{"raw_affiliation_string":"Universitat de Barcelona (UB), Barcelona, Spain","institution_ids":["https://openalex.org/I71999127"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065030410","display_name":"Estefan\u00eda Alcaraz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210126725","display_name":"Grifols (Spain)","ror":"https://ror.org/02ed64f32","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210126725"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Estefan\u00eda Alcaraz","raw_affiliation_strings":["Scientific Innovation Office, Grifols, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Scientific Innovation Office, Grifols, Barcelona, Spain","institution_ids":["https://openalex.org/I4210126725"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016843843","display_name":"Raquel Horrillo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210126725","display_name":"Grifols (Spain)","ror":"https://ror.org/02ed64f32","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210126725"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Raquel Horrillo","raw_affiliation_strings":["Scientific Innovation Office, Grifols, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Scientific Innovation Office, Grifols, Barcelona, Spain","institution_ids":["https://openalex.org/I4210126725"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016932773","display_name":"Javier Ram\u00f3n\u2010Azc\u00f3n","orcid":"https://orcid.org/0000-0002-3636-8013","observed_orcids":["https://orcid.org/0000-0002-3636-8013"]},"institutions":[{"id":"https://openalex.org/I11932220","display_name":"Instituci\u00f3 Catalana de Recerca i Estudis Avan\u00e7ats","ror":"https://ror.org/0371hy230","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I11932220"]},{"id":"https://openalex.org/I4210147769","display_name":"Institute for Bioengineering of Catalonia","ror":"https://ror.org/056h71x09","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210132884","https://openalex.org/I4210147769","https://openalex.org/I4387153040"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Javier Ram\u00f3n-Azc\u00f3n","raw_affiliation_strings":["Biosensors for Bioengineering Group, Institute for Bioengineering of Catalonia (IBEC), Barcelona, Spain","ICREA-Instituci\u00f3 Catalana de Recerca i Estudis Avan\u00e7ats, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biosensors for Bioengineering Group, Institute for Bioengineering of Catalonia (IBEC), Barcelona, Spain","institution_ids":["https://openalex.org/I4210147769"]},{"raw_affiliation_string":"ICREA-Instituci\u00f3 Catalana de Recerca i Estudis Avan\u00e7ats, Barcelona, Spain","institution_ids":["https://openalex.org/I11932220"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5053372670","display_name":"Francesco De Chiara","orcid":"https://orcid.org/0000-0003-1537-1456","observed_orcids":["https://orcid.org/0000-0003-1537-1456"]},"institutions":[{"id":"https://openalex.org/I4210147769","display_name":"Institute for Bioengineering of Catalonia","ror":"https://ror.org/056h71x09","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210132884","https://openalex.org/I4210147769","https://openalex.org/I4387153040"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Francesco De Chiara","raw_affiliation_strings":["Biosensors for Bioengineering Group, Institute for Bioengineering of Catalonia (IBEC), Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biosensors for Bioengineering Group, Institute for Bioengineering of Catalonia (IBEC), Barcelona, Spain","institution_ids":["https://openalex.org/I4210147769"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5016932773","https://openalex.org/A5053372670"],"corresponding_institution_ids":["https://openalex.org/I11932220","https://openalex.org/I4210147769"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"14","issue":null,"first_page":"1798323","last_page":"1798323"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":0.7865999937057495,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":0.7865999937057495,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10966","display_name":"Liver physiology and pathology","score":0.12049999833106995,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12264","display_name":"Tissue Engineering and Regenerative Medicine","score":0.05869999900460243,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/3d-liver-model","display_name":"3D liver model","score":0.8690000176429749},{"id":"https://openalex.org/keywords/drug-induced-liver-injury","display_name":"drug-induced liver injury","score":0.8949999809265137},{"id":"https://openalex.org/keywords/liver-fibrosis","display_name":"liver fibrosis","score":0.9779999852180481},{"id":"https://openalex.org/keywords/hepatic-stellate-cells","display_name":"hepatic stellate cells","score":0.8220000267028809},{"id":"https://openalex.org/keywords/gelatin-methacryloyl","display_name":"gelatin methacryloyl","score":0.6259999871253967},{"id":"https://openalex.org/keywords/lipopolysaccharide","display_name":"lipopolysaccharide","score":0.7919999957084656},{"id":"https://openalex.org/keywords/paracetamol","display_name":"paracetamol","score":0.9819999933242798},{"id":"https://openalex.org/keywords/dexamethasone","display_name":"dexamethasone","score":0.8320000171661377},{"id":"https://openalex.org/keywords/hyperammonemia","display_name":"hyperammonemia","score":0.7860000133514404},{"id":"https://openalex.org/keywords/col1a1","display_name":"COL1A1","score":0.8190000057220459},{"id":"https://openalex.org/keywords/thp-1-cells","display_name":"THP-1 cells","score":0.8360000252723694},{"id":"https://openalex.org/keywords/macrophage-activation","display_name":"macrophage activation","score":0.9919999837875366},{"id":"https://openalex.org/keywords/drug-safety-testing","display_name":"drug safety testing","score":0.6880000233650208},{"id":"https://openalex.org/keywords/hepatocyte-function","display_name":"hepatocyte function","score":0.3889999985694885}],"concepts":[{"id":"https://openalex.org/C2777214474","wikidata":"https://www.wikidata.org/wiki/Q147778","display_name":"Cirrhosis","level":2,"score":0.7472000122070312},{"id":"https://openalex.org/C176891718","wikidata":"https://www.wikidata.org/wiki/Q1997459","display_name":"Hepatic stellate cell","level":2,"score":0.6593999862670898},{"id":"https://openalex.org/C2779102576","wikidata":"https://www.wikidata.org/wiki/Q5113984","display_name":"Chronic liver disease","level":3,"score":0.6244999766349792},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6029999852180481},{"id":"https://openalex.org/C2777075537","wikidata":"https://www.wikidata.org/wiki/Q929737","display_name":"Liver disease","level":2,"score":0.5468000173568726},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5410000085830688},{"id":"https://openalex.org/C2780559512","wikidata":"https://www.wikidata.org/wiki/Q605709","display_name":"Fibrosis","level":2,"score":0.5300999879837036},{"id":"https://openalex.org/C2776200302","wikidata":"https://www.wikidata.org/wiki/Q827450","display_name":"Hepatocyte","level":3,"score":0.5073999762535095},{"id":"https://openalex.org/C2776637226","wikidata":"https://www.wikidata.org/wiki/Q6658207","display_name":"Liver injury","level":2,"score":0.4742000102996826},{"id":"https://openalex.org/C2993667909","wikidata":"https://www.wikidata.org/wiki/Q147778","display_name":"Hepatic fibrosis","level":3,"score":0.40529999136924744},{"id":"https://openalex.org/C2780826214","wikidata":"https://www.wikidata.org/wiki/Q1324974","display_name":"Transient elastography","level":4,"score":0.40220001339912415},{"id":"https://openalex.org/C2778754761","wikidata":"https://www.wikidata.org/wiki/Q421804","display_name":"Lipopolysaccharide","level":2,"score":0.3935999870300293},{"id":"https://openalex.org/C2779244956","wikidata":"https://www.wikidata.org/wiki/Q184204","display_name":"Macrophage","level":3,"score":0.3797000050544739},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.35989999771118164},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.34790000319480896},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.3294000029563904},{"id":"https://openalex.org/C2994217296","wikidata":"https://www.wikidata.org/wiki/Q147778","display_name":"Liver fibrosis","level":3,"score":0.3091000020503998},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.30550000071525574},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3043999969959259},{"id":"https://openalex.org/C49039625","wikidata":"https://www.wikidata.org/wiki/Q84230","display_name":"Secretion","level":2,"score":0.303600013256073},{"id":"https://openalex.org/C195521686","wikidata":"https://www.wikidata.org/wiki/Q17152676","display_name":"Liver cytology","level":3,"score":0.2888999879360199},{"id":"https://openalex.org/C2776125364","wikidata":"https://www.wikidata.org/wiki/Q169219","display_name":"Albumin","level":2,"score":0.28780001401901245},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.2849999964237213},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.27390000224113464}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3389/fbioe.2026.1798323","doi":"https://doi.org/10.3389/fbioe.2026.1798323","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fbioe.2026.1798323","pdf_url":"https://www.frontiersin.org/journals/bioengineering-and-biotechnology/articles/10.3389/fbioe.2026.1798323/pdf","source":{"id":"https://openalex.org/S2595131146","display_name":"Frontiers in Bioengineering and Biotechnology","issn_l":"2296-4185","issn":["2296-4185"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Bioengineering and Biotechnology","raw_type":"journal-article"},{"id":"pmid:42186602","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42186602","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in bioengineering and biotechnology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13198925","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13198925/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Bioeng Biotechnol","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:a16c78752b61443dbc36953de2d9ca85","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/a16c78752b61443dbc36953de2d9ca85","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Bioengineering and Biotechnology, Vol 14 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fbioe.2026.1798323","doi":"https://doi.org/10.3389/fbioe.2026.1798323","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fbioe.2026.1798323","pdf_url":"https://www.frontiersin.org/journals/bioengineering-and-biotechnology/articles/10.3389/fbioe.2026.1798323/pdf","source":{"id":"https://openalex.org/S2595131146","display_name":"Frontiers in Bioengineering and Biotechnology","issn_l":"2296-4185","issn":["2296-4185"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Bioengineering and Biotechnology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320329568","display_name":"Grifols","ror":"https://ror.org/02ed64f32"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7160761852.pdf","grobid_xml":"https://content.openalex.org/works/W7160761852.grobid-xml"},"referenced_works_count":33,"referenced_works":["https://openalex.org/W2011326826","https://openalex.org/W2020504757","https://openalex.org/W2026611803","https://openalex.org/W2070427988","https://openalex.org/W2085652695","https://openalex.org/W2107036592","https://openalex.org/W2133135729","https://openalex.org/W2301260083","https://openalex.org/W2345415005","https://openalex.org/W2357780010","https://openalex.org/W2625311319","https://openalex.org/W2888912936","https://openalex.org/W2965842647","https://openalex.org/W2970924609","https://openalex.org/W3020904210","https://openalex.org/W3035185084","https://openalex.org/W3112281184","https://openalex.org/W3132692795","https://openalex.org/W3158551123","https://openalex.org/W4220722264","https://openalex.org/W4224247826","https://openalex.org/W4285265864","https://openalex.org/W4361001982","https://openalex.org/W4361221098","https://openalex.org/W4386046609","https://openalex.org/W4396834564","https://openalex.org/W4399576605","https://openalex.org/W4399850636","https://openalex.org/W4400775597","https://openalex.org/W4402993620","https://openalex.org/W4403232683","https://openalex.org/W4404002044","https://openalex.org/W4412957433"],"related_works":["https://openalex.org/W7127963945","https://openalex.org/W2970720328","https://openalex.org/W4411253354","https://openalex.org/W7018176762","https://openalex.org/W3127622445","https://openalex.org/W6889883314","https://openalex.org/W4410314771","https://openalex.org/W3080893708","https://openalex.org/W7114908109","https://openalex.org/W2516600274"],"abstract_inverted_index":{"The":[0,112,163,280],"liver":[1,41,45,51,76,110,142,181,242,248],"is":[2,35],"frequently":[3],"exposed":[4],"to":[5,15,62,103,241,287],"acute":[6,106,197,263],"and":[7,18,23,53,78,107,120,130,151,171,178,192,211,234,254,264,277],"chronic":[8,40,56,88,108,265],"insults":[9],"that":[10],"disrupt":[11],"its":[12],"function,":[13],"leading":[14],"inflammation,":[16],"fibrosis,":[17,187],"serious":[19],"conditions":[20,57],"like":[21,58],"cirrhosis":[22],"hepatocellular":[24],"carcinoma.":[25],"Fibrosis,":[26],"driven":[27],"by":[28,175,185],"the":[29,140,216,231,284],"activation":[30],"of":[31,39,115,168,190,230],"hepatic":[32,121,290],"stellate":[33,122],"cells":[34,123],"a":[36,99,126,136,251],"key":[37],"feature":[38],"damage.":[42],"Traditional":[43],"2D":[44,161],"models":[46,66,85,198],"face":[47],"limitations":[48],"in":[49,159],"maintaining":[50],"functions":[52],"accurately":[54],"replicating":[55],"fibrosis.":[59],"In":[60,94,195],"response":[61,233],"these":[63],"needs,":[64],"3D":[65,84,100,141,247],"have":[67],"emerged":[68],"as":[69],"more":[70],"physiologically":[71,145,252],"relevant":[72,146,253],"platforms":[73],"for":[74,220,257,271],"studying":[75,258],"disease":[77,243,275],"drug":[79,272],"testing.":[80],"However,":[81],"most":[82],"existing":[83],"still":[86],"lack":[87],"injury":[89,182],"features":[90],"or":[91],"immune":[92,232],"elements.":[93],"this":[95,246],"study,":[96],"we":[97],"developed":[98],"human-liver":[101],"model":[102,113,164,249],"investigate":[104],"both":[105],"drug-induced":[109],"injury.":[111,203,266],"consists":[114],"encapsulated":[116],"human":[117,225],"hepatocytes":[118],"(HepaRG)":[119],"(LX-2)":[124],"within":[125],"gelatin":[127],"methacryloyl":[128],"(GelMA)":[129],"carboxymethyl":[131],"cellulose":[132],"methacrylate":[133],"matrix.":[134],"Over":[135],"30-day":[137],"culture":[138],"period,":[139],"constructs":[143],"maintained":[144],"functions,":[147],"including":[148],"albumin":[149],"secretion":[150],"cytochrome":[152],"P450":[153],"activity,":[154],"which":[155,237],"are":[156,238],"lost":[157],"rapidly":[158],"conventional":[160],"models.":[162],"enabled":[165],"reliable":[166],"simulation":[167],"low-level,":[169],"long-term,":[170],"high-dose,":[172],"short-term":[173],"damage":[174],"administering":[176],"lipopolysaccharide":[177],"Paracetamol.":[179],"Chronic":[180],"was":[183],"characterized":[184],"progressive":[186],"elevated":[188],"expression":[189],"COL1A1,":[191],"persistent":[193],"hyperammonemia.":[194],"contrast,":[196],"showed":[199],"significant":[200],"but":[201],"transient":[202],"Moreover,":[204],"dexamethasone":[205],"treatment":[206],"successfully":[207],"reversed":[208],"fibrotic":[209],"markers":[210],"restored":[212],"hepatocyte":[213],"functionality,":[214],"indicating":[215],"model's":[217,285],"predictive":[218],"power":[219],"evaluating":[221],"potential":[222],"therapies.":[223],"Incorporating":[224],"monocytes":[226],"(THP-1)":[227],"allowed":[228],"investigation":[229],"macrophage":[235],"activation,":[236],"critical":[239],"contributors":[240],"pathogenesis.":[244],"Overall,":[245],"offers":[250],"versatile":[255],"platform":[256],"complex":[259],"multi-cellular":[260],"interactions":[261],"under":[262],"It":[267],"has":[268],"broad":[269],"implications":[270],"safety":[273],"screening,":[274],"modeling,":[276],"personalized":[278],"therapy.":[279],"tri-culture":[281],"design":[282],"extends":[283],"capacity":[286],"elucidate":[288],"immune-driven":[289],"pathology.":[291]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7160761852","counts_by_year":[],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2026-05-11T00:00:00"}
